Topical ruxolitinib for ocular mucous membrane pemphigoid
Аннотация
Publication date: December 2026 Source: Journal Français d'Ophtalmologie, Volume 49, Issue 10 Author(s): Billal Tedbirt, Pascal Joly, Marc Muraine, Julie Gueudry
Publication date: December 2026 Source: Journal Français d'Ophtalmologie, Volume 49, Issue 10 Author(s): Billal Tedbirt, Pascal Joly, Marc Muraine, Julie Gueudry
Acta Ophthalmologica, EarlyView.
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Clinical &Experimental Ophthalmology, EarlyView.
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...